arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL
$312.93 ▼ -13.39 (-4.10%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
19 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
39
Health
Weak
Bearish
auto_awesome

Analytical Summary

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $15.5B
Dividend Yield —
Revenue Growth -0.9% ↗
Op. Margin 0.6% ↘
ROIC 1.1% ↘
FCF / Share $14.88 ↗
Trailing P/E —
Price / Book 4.9x
FCF Yield 4.8%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$4.02B
↓ -0.9% —
Net Income Profit after all expenses
$-144.34M
↓ -750.1% —
Operating Margin Operating profit as % of sales
0.6%
↓ -88.8% 30th
FCF / Share Free cash flow per share
$14.88
↑ +4.1% —
Long-Term Debt Long-term obligations
$1.61B
↑ +48.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
45
Returns
39
Financial Health ↓
50
Cash Quality
3

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 19 years · 72 quarters